EUVIMEDEUVIMED entdecken
Crossref

Protective effect of leukotriene receptor antagonist, montelukast, against cyclophosphamide-induced placental toxicity via modulation of NLRP3/IL-1β signaling pathway in rats

Walaa Yehia Abdelzaher, Salwa Abdeltwab Ibrahim, Seham Abdel-Wakeel Abdel-Gaber, Rania Rady Fadl, Nada Amgad Mohamed, Wael F Sedik, Asmaa Mohamed Abdel-Aziz

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Walaa Yehia Abdelzaher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine Minia University, Minia 61111, Egypt. Electronic address: walaa.hamada@mu.edu.eg. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Cyclopropanes, Cyclophosphamide, Quinolines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDS & AIM: Placental insufficiency is a serious complication that affects pregnancy and fetal growth. Cyclophosphamide (CYC) is considered one of the chemotherapeutic agents. Unfortunately, CYC not only affects tumor cells but also affects healthy cells causing multiple injuries including the placenta. The present study aimed to evaluate the effect of cysteinyl leukotriene receptor antagonist; montelukast (MK), on CYC-induced placental injury in rats. MATERIALS AND METHODS: Forty-eight female Wister rats were randomly divided into 8 experimental groups. Group 1: control pregnant group; Group 2: MK 5 mg-treated pregnant rats; Group 3: MK 10 mg-treated pregnant rats; Group 4: MK 20 mg-treated pregnant rats; Group 5: pregnant rats received CYC (20 mg/kg, i.p); Group 6: pregnant rats received MK 5 mg and CYC; Group 7: pregnant rats received MK 10 mg and CYC; Group 8: pregnant rats received MK 20 mg and CYC. Placental malondialdehyde (MDA), reduced glutathione (GSH), total antioxidant capacity (TAC), placental growth factor (PlGF), and Nod-like receptor p3 (NLRP3) inflammasome were measured. Histological changes, interleukin-1β (IL-1β), and cleaved caspase-3 immuno-expressions were also evaluated. RESULTS: CYC showed a significant decrease in placental GSH, TAC, and PlGF with a significant increase in placental MDA, NLRP3, and immuno-expression of IL-1β and caspase-3. MK showed significant improvement in all oxidative stress (MDA, GSH and TAC), inflammatory (NLRP3 and IL-1β), and apoptotic (caspase-3) parameters. CONCLUSION: According to the findings, MK was proved to have a possible protective role in CYC-induced placental injury via modulation of NLRP3/IL-1β signaling pathway with anti-oxidant, anti-inflammatory, and anti-apoptotic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinCyclopropanesCyclophosphamideQuinolinesAcetatesInterleukin-1betaPlacentaLeukotriene AntagonistsSignal TransductionSulfidesRats, WistarAnimalsFemalePregnancyRatsPlacenta Growth FactorOxidative StressInflammasomesApoptosis

Stichwörter der Autor:innen

CyclophosphamideIL-1βMontelukastNLRP3Placenta

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinmontelukastCyclopropanesCyclophosphamideQuinolinesAcetatesInterleukin-1betaLeukotriene AntagonistsSulfidesNlrp3 protein, rat

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Faculty of Medicine Minia University, Minia 61111, Egypt. Electronic address: walaa.hamada@mu.edu.eg.
  • Department of Medical Pharmacology, Faculty of Medicine Minia University, Minia 61111, Egypt.
  • Department of Medical Pharmacology, Faculty of Medicine Minia University, Minia 61111, Egypt. Electronic address: dr_raniaradyfadl@yahoo.com.
  • Department of Histology and Cell Biology, Faculty of Medicine, 61511, Egypt.
  • Department of Medical Biochemistry, Faculty of Medicine, Minia University, Egypt. Electronic address: wael.hassanain@mu.edu.eg.

Zitieren

APA

Yehia Abdelzaher, W., Abdeltwab Ibrahim, S., Abdel-Wakeel Abdel-Gaber, S., Rady Fadl, R., Amgad Mohamed, N., Sedik, W. F., & Mohamed Abdel-Aziz, A. (2024). Protective effect of leukotriene receptor antagonist, montelukast, against cyclophosphamide-induced placental toxicity via modulation of NLRP3/IL-1β signaling pathway in rats. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112700

Vancouver

Yehia Abdelzaher W, Abdeltwab Ibrahim S, Abdel-Wakeel Abdel-Gaber S, Rady Fadl R, Amgad Mohamed N, Sedik WF, et al. Protective effect of leukotriene receptor antagonist, montelukast, against cyclophosphamide-induced placental toxicity via modulation of NLRP3/IL-1β signaling pathway in rats. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112700

BibTeX
@article{YehiaAbdelzaher2024,
  author = {Yehia Abdelzaher, Walaa and Abdeltwab Ibrahim, Salwa and Abdel-Wakeel Abdel-Gaber, Seham and Rady Fadl, Rania and Amgad Mohamed, Nada and Sedik, Wael F and Mohamed Abdel-Aziz, Asmaa},
  title = {Protective effect of leukotriene receptor antagonist, montelukast, against cyclophosphamide-induced placental toxicity via modulation of NLRP3/IL-1β signaling pathway in rats},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112700}
}
Kostenlos starten →